Home / News / Asbestos Exposure & Bans

Johnson & Johnson to Continue Global Sale of Talc-Based Baby Powder

Asbestos Exposure & Bans

Reading Time: 4 mins

Publication Date: 05/09/2022

Written by Tim Povtak

Fact Checked

Cite This Article

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

Assisting mesothelioma patients and their loved ones since 2006.
Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
A+ rating from the Better Business Bureau.
5-star reviewed mesothelioma and support organization.

Learn More About Us

Testimonials

My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.

Lashawn

Mesothelioma patient’s daughter

Read Our Testimonials

Johnson & Johnson will continue selling its iconic talc-based baby powder outside the United States and Canada after shareholders rejected a proposal that would have ended its worldwide production and distribution.

The proposal failed to receive the majority vote needed at J&J’s annual meeting of stockholders last month, which was held virtually due to the COVID-19 pandemic. Ending global sales was one of 14 issues – and the most controversial – listed in the company’s proxy statement.

J&J discontinued selling Johnson’s Baby Powder throughout the U.S. and Canada in 2020 after being flooded with lawsuits claiming long-term use of its product was causing serious health issues stemming from talc contaminated by asbestos fibers.

The most serious issues involved ovarian and mesothelioma cancer. An estimated 40,000 talc lawsuits have been filed.

J&J Shareholders Have Their Say

The litigation stemming from those lawsuits already has cost Johnson & Johnson close to $1 billion in legal fees and $3.5 billion in settlements and verdicts, according to the company. At least 25,000 cases are still outstanding today.

Along with the ballot, the shareholder proposal included lengthy statements from management encouraging rejection of worldwide talc sales, and statements from proposal authors urging its passage.

“J&J remains vulnerable to further erosion of its reputation as a trusted purveyor of health-related products by continuing to sell and market its talc-based baby powder to the rest of the world,” wrote proposal author Antoine Argouges, CEO of Tulipshare Ltd. “The use of talc in personal care products is a public health concern.”

The U.S. Food and Drug Administration discovered small traces of asbestos in baby powder samples taken in 2019, which prompted a partial recall. Less than a year later, Johnson & Johnson suspended sales of the talc-based product in the U.S. and Canada.

“This is no longer a political, or legal, or consumer problem,” Argouges wrote. “This is a shareholder problem.”

Johnson & Johnson Says Talc Baby Powder Is Safe

Johnson & Johnson has continued to insist its product is safe, attributing the stoppage of sales to exaggerated reports of contamination, legal ramifications and lagging interest in the product. It insists that its regular testing of talc has proven there is no toxic asbestos contamination.

Talc, a naturally occurring mineral, is often mined near asbestos deposits close to the Earth’s surface, increasing the risk of asbestos contamination.

“The company continues to use cosmetic talc in Johnson’s Baby Powder because decades of science have reaffirmed its safety,” management wrote in its opposition to the proxy proposal. “Decades of independent scientific testing has confirmed that JBP [Johnson’s Baby Powder] is safe and is not contaminated with asbestos.”

Johnson & Johnson, one of America’s richest companies, has a market share estimated at $450 billion. A major reason for its desire to continue marketing its talc-based baby powder was its recent ability to create a new subsidiary to separate assets from liabilities.

The newly created entity, called LTL Management LLC, immediately filed for bankruptcy protection. A federal judge in New Jersey approved the Chapter 11 bankruptcy plan in February. J&J will now avoid a much more costly and drawn-out route of litigating individual lawsuits.

Although details of the bankruptcy filing are still ongoing, LTL Management has listed its net worth at $10 billion, along with $10 billion in liabilities. Johnson & Johnson has set aside an additional $2 billion to be distributed through the pending bankruptcy trust.

“These actions are not a concession of liability, but rather a means to achieve an equitable and efficient resolution of the claims raised in the talc litigation,” management wrote in the proxy. “The claims are premised on the allegation that talc causes ovarian cancer and mesothelioma, a position that has been rejected by independent experts.”